BLUEBIRD BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9228 USD | +1.13% |
|
-9.53% | -33.13% |
| 04-26 | Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report | MT |
| 03-27 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
Chart calendar bluebird bio, Inc.
d98a330a331d863d9905.M6oI1Hm2OCCwDw6fLl1iqcx2TB1uKKbAxk5rxJTMYN4.AeNJoTHbSEbIVl_HeBIT0_g6ACQaUf7zg3oisdj9Fa5c6DCHAeFuEPM5Sw~5c89a7e0332eb2ef455560359323042c
Upcoming events on bluebird bio, Inc.
Past events on bluebird bio, Inc.
| 26/03/2024 12:00 | Q4 2023 Earnings Call |
| 26/03/2024 11:00 | Q4 2023 Earnings Release |
| 09/01/2024 18:30 | JPMorgan Healthcare Conference |
| 12/12/2023 00:30 | American Society of Hematology Meeting - Oral No :#1051 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Poster No:#2480 |
| 10/12/2023 01:30 | American Society of Hematology Meeting - Poster No:#1102 |
| 08/12/2023 21:15 | FDA Approved Call |
| 07/11/2023 13:00 | Q3 2023 Earnings Call |
| 07/11/2023 12:00 | Q3 2023 Earnings Release |
| 12/09/2023 19:00 | Baird Global Healthcare Conference |
| 11/09/2023 17:15 | Morgan Stanley Global Healthcare Conference |
| 08/08/2023 13:00 | Q2 2023 Earnings Call |
| 08/08/2023 12:00 | Q2 2023 Earnings Release |
| 16/06/2023 13:30 | Annual General Meeting |
| 13/06/2023 00:40 | Goldman Sachs Global Healthcare Conference |
| 11/05/2023 16:15 | Bank of America Healthcare Conference |
| 09/05/2023 12:00 | Q1 2023 Earnings Release |
| 29/03/2023 13:00 | Q4 2022 Earnings Call |
| 29/03/2023 12:00 | Q4 2022 Earnings Release |
| 12/01/2023 15:30 | JP Morgan Healthcare Conference |
Past dividends on bluebird bio, Inc.
| 04/11/2021 | 0 |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 54,6 43,0 26.85% | 44,7 43,4 2.92% | 251 259 -3.22% | 3,66 48,0 -92.37% | 3,60 40,9 -91.2% | 37,4 |
|
EBITDA Million USD | Released Forecast Spread | -555 -559 0.68% | -797 -766 -4.12% | -604 -608 0.72% | -571 -791 27.76% | -379 -324 -16.94% | -266 |
|
EBIT Million USD | Released Forecast Spread | -572 -573 0.09% | -815 -804 -1.32% | -623 -624 0.18% | -591 -811 27.18% | -384 -363 -5.96% | -283 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -555 -562 1.1% | -790 -782 -1.03% | -618 -623 0.77% | -562 -759 25.86% | -266 -319 16.37% | -199 |
|
Net income Million USD | Released Forecast Spread | -556 -562 1.07% | -790 -781 -1.04% | -619 -624 0.79% | -819 -762 -7.49% | -267 -332 19.71% | -199 |
|
EPS USD | Released Forecast Spread | -10,7 -10,8 1.01% | -14,3 -14,1 -1.78% | -9,95 -9,94 -0.13% | -11,9 -10,8 -10.32% | -3,39 -3,94 14.02% | -1,66 |
| Announcement Date | 21/02/19 | 18/02/20 | 23/02/21 | 04/03/22 | 29/03/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 22,7 41,5 -45.34% | 1,61 5,08 -68.41% | 1,95 0,17 1066.98% | 1,52 0,71 115.02% | 0,07 1,07 -93.39% | 0,06 15,4 -99.6% | 2,38 27,0 -91.17% | 6,89 11,3 -38.77% | 12,4 13,4 -7.57% | 13,9 | 19,2 | 21,8 | 31,9 | 51,7 |
|
EBITDA Million USD | Released Forecast Spread | -191 -176 -8.51% | -133 -116 -14.63% | -119 -87,7 -36.08% | -99,4 -90,6 -9.77% | -85,1 -78,0 -9.09% | -75,3 -33,5 -124.8% | -83,4 -28,5 -192.67% | -84,3 -79,1 -6.57% | -83,7 -81,9 -2.1% | -102 | ||||
|
EBIT Million USD | Released Forecast Spread | -197 -176 -11.59% | -136 -123 -9.97% | -120 -109 -10.72% | -101 -93,7 -7.5% | -86,5 -81,5 -6.09% | -76,6 -81,7 6.23% | -84,5 -36,3 -132.8% | -85,3 -76,1 -12.08% | -84,7 -81,1 -4.54% | -86,7 | -75,7 | -71,8 | -65,3 | -53,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -217 -179 -20.87% | -132 -127 -4.39% | -122 -108 -13.13% | -100 -99,8 -0.37% | -76,5 -84,9 9.89% | 32,3 -81,2 139.83% | 21,2 -3,97 634.53% | -73,0 -74,1 1.51% | -71,7 -77,4 7.31% | -78,4 | -70,0 | -66,4 | -59,7 | -46,3 |
|
Net income Million USD | Released Forecast Spread | -217 -179 -21.23% | -155 -121 -28.45% | -122 -103 -18.99% | -100 -95,5 -4.83% | -76,5 -86,3 11.34% | 32,2 -86,1 137.42% | 21,2 -23,5 190.25% | -72,9 -73,8 1.15% | -71,7 -75,8 5.32% | -82,5 | -67,9 | -65,9 | -59,0 | -44,8 |
|
EPS USD | Released Forecast Spread | -3,16 -2,52 -25.57% | -2,14 -1,76 -21.83% | -1,66 -1,36 -22.26% | -1,36 -1,29 -5.7% | -0,94 -1,18 20.34% | 0,38 -0,20 288.95% | 0,21 -0,31 167.57% | -0,67 -0,71 5.03% | -0,66 -0,67 2.2% | -0,63 | -0,43 | -0,42 | -0,37 | -0,30 |
| Announcement Date | 05/11/21 | 04/03/22 | 09/05/22 | 04/08/22 | 07/11/22 | 29/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | - | - | - | - | - |
More events
Past sector events for bluebird bio, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BLUE Stock
- Calendar bluebird bio, Inc.
